Preclinical evaluation of an automated closed fluid management device: Cytomate™, for washing out DMSO from hematopoietic stem cell grafts after thawing

Bone Marrow Transplantation

Volumn 31, Issue 9, 2003, Pages 823-828

  Calmels, B ^a   Houze P ^b   Hengesse, J C ^c   Ducrot, T ^c   Malenfant, C ^a   Chabannon, C ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Baxter Oncologie ^*  (France)

Author keywords

Autologous transplantation; Capillary zone eletrophoresis; Cryopreservation; DMSO; Hematopoietic stem cells; High dose chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; DIMETHYL SULFOXIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; AUTOMATION; CELL DESTRUCTION; CELL LOSS; CELL VIABILITY; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYOPRESERVATION; DISEASE SEVERITY; GOOD MANUFACTURING PRACTICE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE SUBPOPULATION; MALIGNANT NEOPLASTIC DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REPRODUCIBILITY; SOLID TUMOR; T LYMPHOCYTE; THAWING;

AUTOMATION; BLOOD COMPONENT REMOVAL; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTE COUNT; REPRODUCIBILITY OF RESULTS; TISSUE PRESERVATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0037737468     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703905     Document Type: Article

References (26)

1. Zambelli A, Poggi G, Da Prada G et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705-4708.
2. Okamoto Y, Takaue Y, Saito S et al. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993; 33: 578-581.
3. Alessandrino P. Bernasconi P, Caldera D et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533-537.
4. Lopez-Jimenez J, Cervero C, Munoz A et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994; 13: 789-973.
5. Perseghin P, Balduzzi A, Bonanomi S et al. Infusion-related side-effects in children undergoing autologous hematopoietic stem cell transplantation for acute leukemia. Bone Marrow Transplant 2000; 26: 116-118.
6. Davis JM, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781-786.
7. Styler MJ, Topolsky DL, Crilley PA et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992; 10: 435-438.
8. Keung YK, Lau S, Elkayam U et al. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994; 14: 363-367.
9. Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994; 12: 998-1004.
10. Dhodapkar M, Goldberg SL, Tefferi A et al. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994; 45: 187-188.
11. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285-1287.
12. Rapoport AP, Rowe JM, Packman CH et al. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991; 7: 401-403.
13. Bond GR, Curry SC, Dahl DW. Dimethylsulphoxide-induced encephalopathy. Lancet 1989; 1: 1134-1135.
14. Kessinger A, Armitage JO, Smith DM et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989; 74: 1260-1265.
15. Shpall E, LeMaistre CF, Holland K et al. A prospective randomized trial of buffy-coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high dose chemotherapy. Blood 1997; 90: 4313-4320.
16. Chabannon C, Cornetta K, Lotz JP et al. High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicenter study. Br J Cancer 1998; 78: 913-921.
17. Yanovich S, Mitsky P, Cornetta K et al. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial. Bone Marrow Transplant 2000; 25: 1165-1174.
18. Stewart AK, Vescio R, Schiller G et al. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial. J Clin Oncol 2001; 19: 3771-3779.
19. Ayello J, Hesdorffer C, Reiss RF. A semiautomated technique for volume reduction of stem cell suspensions for autotransplantation. J Hematother 1995; 4: 545-549.
20. Del Mastro L, Venturini M, Viscoli C et al. Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients. Ann Oncol 2001; 12: 505-508.
21. Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119-10122.
22. Beaujean F, Hartmann O, Kuentz M et al. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991; 8: 291-294.
23. Olivero S, Alario T, Ladaique P et al. CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol. Bone Marrow Transplant 1999; 23: 387-394.
24. Keeney M, Chin-Yee I, Weir K et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998; 34: 61-70.
25. Metcalf D. Techniques for the Clonal Culture of Hemopoietic Cells: Techniques and Applications. Elsevier: New York, 1984.
26. Houze P, Dal Cortivo L, Anselme M et al. Quantification of residual dimethyl sulfoxide in supernatants of haematopoietic stem cells by capillary zone electrophoresis. J Chromatogr B Biomed Sci Appl 1999; 728: 75-83.